感染性休克时使用短效β1受体阻滞剂可能通过降低心率抑制血流动力学而减少脑组织氧合
该研究将17头猪分配至兰地洛尔组或对照组,兰地洛尔剂量从0依次增至40、200 μg/kg/min后停药,并在脂多糖持续输注后30分钟和150分钟两个内毒素血症阶段重复给药测量。内毒素血症1阶段,兰地洛尔恢复每搏量至内毒素前水平,即使在200 μg/kg/min也未降低心输出量;内毒素血症2阶段,兰地洛尔未能恢复每搏量,导致心输出量和平均动脉压下降,并伴随脑组织氧合指数剂量依赖性降低。结论认为短效β1阻滞剂在内毒素血症中具有多种血流动力学效应,若心率下降导致血流动力学抑制,可能降低脑组织氧合。
要点
- 内毒素血症1阶段(脂多糖后30分钟),兰地洛尔恢复每搏量至内毒素前水平,即使在200 μg/kg/min也未降低心输出量。
- 内毒素血症2阶段(脂多糖后150分钟),兰地洛尔未能恢复每搏量,导致心输出量和平均动脉压下降,并伴随脑组织氧合指数剂量依赖性降低。
- 兰地洛尔剂量从0增至40、200 μg/kg/min后停药,各内毒素血症阶段均降低心率。
- 若心率下降导致血流动力学抑制,使用短效β1阻滞剂可能减少脑组织氧合。
适用人群与场景
- 17头猪的内毒素血症模型,脂多糖以100 μg推注后以1 μg/kg/h持续输注,在内毒素血症后30分钟(内毒素血症1)和150分钟(内毒素血症2)两个阶段评估。
处置流程与药物剂量
- 兰地洛尔组剂量依次从0增至40、200 μg/kg/min,然后停止。
- 脂多糖先以100 μg推注,随后以1 μg/kg/h持续输注。
研究设计与关键结果
- 研究类型为动物实验,17头猪分配至兰地洛尔组或对照组,兰地洛尔组按0、40、200 μg/kg/min序贯给药后停药,在脂多糖后30分钟(内毒素血症1)和150分钟(内毒素血症2)重复测量。
- 内毒素血症1阶段,脂多糖降低每搏量,兰地洛尔恢复每搏量至内毒素前水平,即使在200 μg/kg/min也未降低心输出量。
- 内毒素血症2阶段,兰地洛尔未恢复每搏量,导致心输出量和平均动脉压下降,并伴随脑组织氧合指数剂量依赖性降低。
- 脂多糖增加心率,兰地洛尔降低心率,各内毒素血症阶段效果相似。
证据类型、等级与局限
- 证据类型:动物实验(猪内毒素血症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在内毒素血症期间使用短效β1阻滞剂,若心率下降导致血流动力学抑制,可能减少脑组织氧合。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: A decrease in heart rate (HR) using a short-acting β blocker has potential benefits in sepsis; however, depression of hemodynamics and reduction of cerebral oxygenation may also occur in endotoxemia.
METHODS: Seventeen swine were allocated to landiolol or control groups. In the landiolol group, the dose was sequentially changed from 0 to 40 to 200 μg kg min, and stopped. Hemodynamics, blood variables, and the cerebral tissue oxygenation index (TOI) were recorded by near infrared spectroscopy at each dose. Lipopolysaccharide (LPS) was then administered continuously at 1 μg kg h after a 100 μg bolus administration. After 30 and 150 min, as two severity stages of endotoxemia (endotoxemia 1 and 2), landiolol was administered as above and measurements were made. In the control group, landiolol was not administered, but measurements were made.
RESULTS: LPS increased HR and landiolol decreased HR, with similar effects in each endotoxemia stage. In endotoxemia 1, LPS decreased stroke volume (SV), but landiolol restored SV to a value similar to that before endotoxemia, and did not decrease cardiac output (CO), even at 200 μg kg min. In contrast, landiolol did not restore SV in endotoxemia 2, resulting in a decrease in CO and mean arterial pressure, accompanied with a dose-dependent decrease in TOI.
CONCLUSIONS: A short-acting β blocker has various hemodynamic effects in endotoxemia. Use of a short-acting β blocker during endotoxemia may reduce cerebral tissue oxygenation if hemodynamics are depressed by a decrease in HR.
参考来源
- Kurita T, Kawashima S, Morita K, et al. Use of a Short-Acting β1 Blocker During Endotoxemia May Reduce Cerebral Tissue Oxygenation if Hemodynamics are Depressed by a Decrease in Heart Rate. Shock. 2017. PMID: 28505021. doi:10.1097/SHK.0000000000000795
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。